Form 4: Phio Pharmaceuticals CEO Robert Bitterman Boosts Stake with Recent Stock Purchase

Phio Pharmaceuticals Corp.'s Chairman, President, and CEO, Robert J. Bitterman, has increased his direct ownership in the company by purchasing 2,000 shares of common stock.

Summary

• Robert J. Bitterman, who serves as Director, 10% Owner, and Chairman, President & CEO of Phio Pharmaceuticals Corp. (PHIO), acquired 2,000 shares of the company's common stock.
• The transaction took place on June 10, 2025, with the shares purchased at a price of $2.42 per share.
• Following this acquisition, Mr. Bitterman directly beneficially owns a total of 27,149 shares of Phio Pharmaceuticals common stock.
• The reported beneficial ownership includes shares of common stock underlying unvested restricted stock units.

Sentiment

Score: 8

Explanation: The direct purchase of company stock by the Chairman, President, and CEO is a strong positive signal, indicating high confidence in the company's prospects and potentially signaling future positive developments.

Positives

• The Chairman, President, and CEO, Robert J. Bitterman, directly purchased 2,000 shares of common stock, signaling strong confidence in the company's future prospects and valuation.
• Insider buying by a top executive can be interpreted as a positive indicator for investors, suggesting that management believes the stock is undervalued or has significant upside potential.

Future Outlook

NA

Industry Context

This Form 4 filing reports an insider stock purchase, which is a common occurrence across various industries. It primarily reflects an individual executive's belief in their company's value and future performance, rather than broader industry trends or competitive dynamics.

Stakeholder Impact

• Shareholders: May view the insider purchase as a strong positive signal of confidence from management, potentially leading to increased investor interest or stability in the stock price.
• Employees: Could interpret the CEO's personal investment as a sign of stability and belief in the company's long-term success, potentially boosting morale.

Key Dates

Recommendation

Keywords

Phio Pharmaceuticals Corp., PHIO, Insider Trading, Form 4, Stock Purchase, Robert J. Bitterman, CEO, Director, Beneficial Ownership, Equity